Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TX/Irving
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Irving, TX

Studies commonly pay $75 to $4,500 per completed study

2,008 clinical trials are currently recruiting participants within 30 miles of Irving. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

2,008studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Irving right now

Top 25 of 2,008 recruiting studies, sorted by proximity — each links to its official registry page

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Generalized Myasthenia Gravis N/A Observational 500 participants sought
Clinical Trial Site — Dallas, Texas (10.8 mi) · Sponsor: Alexion Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04202341)

A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

Prostate Cancer, Prostate Adenocarcinoma Phase 2 Interventional 90 participants sought
University of Texas Southwestern Medical Center — Dallas, Texas (10.8 mi) · Sponsor: University of Chicago
See eligibility & contact on ClinicalTrials.gov (NCT05726292)

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Phase 1 Interventional 604 participants sought
Sarah Cannon Research Institute at Mary Crowley — Dallas, Texas (10.8 mi) · Sponsor: Revolution Medicines, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06040541)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Medical City Dallas Hospital — Dallas, Texas (10.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Hematuria - Cause Not Known N/A Interventional 1,000 participants sought
UT Southwestern Medical Center — Dallas, Texas (10.8 mi) · Sponsor: Pacific Edge Limited
See eligibility & contact on ClinicalTrials.gov (NCT06394869)

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

Locally Advanced Solid Tumor, Metastatic Solid Tumor Phase 1 Interventional 30 participants sought
Texas Oncology — Dallas, Texas (10.8 mi) · Sponsor: Acepodia Biotech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06415487)

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

Limited Stage Small Cell Lung Cancer Phase 2 Interventional 250 participants sought
Texas Oncology - DFW — Dallas, Texas (10.8 mi) · Sponsor: SCRI Development Innovations, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06773910)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
Texas Oncology DFW — Dallas, Texas (10.8 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Triple Negative Breast Cancer, HER2-negative Breast Cancer Phase 1 Interventional 96 participants sought
Dren Investigational Site — Dallas, Texas (10.8 mi) · Sponsor: Dren Bio
See eligibility & contact on ClinicalTrials.gov (NCT06999187)

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

Niemann-Pick Type C Disease, GM1 Gangliosidosis Phase 3 Interventional 147 participants sought
Children's Medical Center Dallas — Dallas, Texas (10.8 mi) · Sponsor: Azafaros B.V.
See eligibility & contact on ClinicalTrials.gov (NCT07054515)

A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)

Transfusion-dependent Alpha-Thalassemia, Transfusion-dependent Beta-Thalassemia Phase 3 Interventional 54 participants sought
University of Texas Southwestern Medical Center — Dallas, Texas (10.8 mi) · Sponsor: Agios Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07506863)

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications Phase 3 Interventional 115 participants sought
Baylor Scott and White Research Institute (Adults only) — Dallas, Texas (10.8 mi) · Sponsor: Pierre Fabre Medicament
See eligibility & contact on ClinicalTrials.gov (NCT03394365)

Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity

Physical Inactivity, Phosphate Overload N/A Interventional 124 participants sought
University of Texas Southwestern — Dallas, Texas (10.8 mi) · Sponsor: University of Texas Southwestern Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT05147909)

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma Phase 1 Interventional 168 participants sought
University of Texas Southwestern Medical Center — Dallas, Texas (10.8 mi) · Sponsor: OncoNano Medicine, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06022029)

Hyperpolarized 13C Pyruvate-MRI and FDG-PET in a Single Exam for the Prognosis of Ischemic Cardiomyopathy

Coronary Artery Disease, Coronary Artery Bypass Graft (CABG) N/A Observational 15 participants sought
University of Texas Southwestern Medical Center — Dallas, Texas (10.8 mi) · Sponsor: University of Texas Southwestern Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT06814587)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
UT Southwestern Medical Center ( Site 0190) — Dallas, Texas (10.8 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis Phase 2 Interventional 164 participants sought
WISPer site in Dallas, TX — Dallas, Texas (10.8 mi) · Sponsor: Mediar Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06967805)

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

Locally Advanced or Metastatic Solid Tumors, Colorectal Cancer Phase 1 Interventional 572 participants sought
NEXT Dallas — Irving, Texas (3.3 mi) · Sponsor: ArriVent BioPharma, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07066657)

Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well

Acute Ischemic Stroke N/A Interventional 408 participants sought
Baylor University Medical Center — Dallas, Texas (10.8 mi) · Sponsor: Amrou Sarraj
See eligibility & contact on ClinicalTrials.gov (NCT07115940)

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus N/A Interventional 400 participants sought
Revival Research Institute — Denton, Texas (26.4 mi) · Sponsor: Medtronic MiniMed, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07228117)
Actively enrolling

Studies you may be able to join near Irving

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Irving

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

DM Clinical Research- Irving

★ 4.3
Medical Office Building II, 2021 N MacArthur Blvd Ste 450, Irving, TX 75061
(945) 298-0007
"Great Clinical Place to pretesapate! Love the Team very nice caring people there."
— Janie Torres, 5★

Rcts Inc

★ 4.2
3207 Esters Rd, Irving, TX 75062
(972) 871-7578
"They are very well-organized. Friendly staff and very quick which of the businesses were more like that"
— Cammille Jones, 5★

North Texas Clinical Research

1110 Cottonwood Ln, Irving, TX 75038
(972) 258-7462

Tekton Research

★ 4.0
210 W John Carpenter Fwy #100, Irving, TX 75039
(214) 894-5414
"Keeps spamming me with texts and phone calls trying to get me to sign up for clinical trials. I have never had any contact with this group and have n…"
— CB, 1★

Fortrea Clinical Research Unit

★ 3.4
1341 W Mockingbird Ln, Dallas, TX 75247
"While some staff are a little rough around the edges, I really love how they are transparent about things! You ask questions, you will get answers in…"
— Robert Hubbard, 5★

SouthWest Clinical Research

★ 5.0
8989 Harry Hines Blvd, Dallas, TX 75235
(469) 893-1242

UT Southwestern Medical Center: Research Department

★ 3.3
6000 Harry Hines Blvd, Dallas, TX 75235
(214) 633-0022
"Thanks for all the hard work and effort that went into this beautiful building. Thanks for the staff that work here to save lives!"
— Robert Starr, 5★

Baylor Scott & White Research Institute

★ 5.0
3434 Live Oak St Ste 501, Dallas, TX 75204
(214) 820-2687
"My Dr thru my insurance set up an appoint for the Vaccine. From arrival time 45 minutes & done💕Course I did have to go to Hall St in Dallas. It was …"
— Debbie Stewart, 5★

Pillar Clinical Research, Richardson, Texas

★ 4.8
630 N Coit Rd Ste.2200, Richardson, TX 75080
(214) 396-4844
"Berry beautiful place valm the Staff are very admint about about take care of you it was a beautiful experience I love you all. I would definitely re…"
— Vig Dall, 5★

Clinical trials in Irving: what's recruiting

The Irving area currently has 2,008 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Irving, the most active research areas are:

  • Cancer & Oncology11 studies
  • Diabetes & Metabolism2 studies
  • Liver & Kidney1 studies
  • Lungs & Breathing1 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Irving, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Irving

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Irving participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Irving pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Irving?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Irving safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Irving, TX?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Irving typically complete one or two studies per year.

Paid clinical trials near Irving

Other metros within reach

Grand Prairie, TX1,979 Dallas, TX1,890 Arlington, TX1,892 Plano, TX1,841 Frisco, TX1,840 Garland, TX1,849 Fort Worth, TX623 Mesquite, TX1,792

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Irving Chronic Kidney Disease (HealthMatch) in Irving Bladder Issues Due To Spinal Cord Injury in Irving All conditions

More of TX

Houston3,066 Pasadena3,004 Grand Prairie1,979 Arlington1,892 Dallas1,890 Garland1,849 Plano1,841 Frisco1,840 Mesquite1,792 San Antonio1,018 Austin748

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts